This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
June 09, 2015
Cerenis Therapeutics announces new Board members
June 04, 2015
Oncopeptides to Present Promising Phase I/ II Clinical Data at the European Hematology Association in Vienna, Austria, June 11 – 14 2015
June 02, 2015
Nasal Cavity Cooling for Migraine Trial, Utilizing BeneChill’s Proprietary Cooling System, Wins NHS’s 12th Bright Ideas in Health Awards
June 01, 2015
ULI HACKSELL, Ph.D., JOINS GLIONOVA AS CHAIRMAN OF THE BOARD
May 27, 2015
NORDIC NANOVECTOR: RESULTS FOR THE FIRST QUARTER 2015
May 26, 2015
Cerenis Therapeutics featured prominently at the INTERNATIONAL SYMPOSIUM ON ATHEROSCLEROSIS (IAS)
May 26, 2015
Onxeo Announces Final Data from Completed Phase II Trial of Validive® for the Prevention of Severe Oral Mucositis in Head and Neck Cancer Patients
May 21, 2015
NORDIC NANOVECTOR APPOINTS NEW SCIENTIFIC ADVISORY BOARD
May 15, 2015
Statement by the Board of Directors of Aerocrine in relation to Circassia’s public cash offer
May 15, 2015
Cortendo Adds Two Late-Stage Assets to Its Rare Endocrine Disease Franchise and Announces Related $33.2 Million Financing